Melcap developed Wireless Ingestible Capsule Systems for the treatment of Overweight and Obesity.
Melcap developed a novel medical paradigm for the treatment of obesity and overweight, based on the combination of several types of electrical stimulation types, which are synchronized with the user’s meal schedule.
Melcap Systems comprise a disposable capsule, wearable unit and proprietary mobile application installed on user’s Android or IOS smartphone. The capsule operation is wirelessly monitored by a mobile application’s sophisticated algorithm, allowing implementation of modern Brain-Gut Axis paradigm which helps users to suppress the appetite and finally lose weight.
Melcap optimized its therapeutic algorithm by using the results of the measured physiological parameters such as pH, temperature, impedance and gastric transient time, which allows to locate the capsule and use specific stimulation shapes in different parts of the digestive system. Such kind of therapy is made in patient-tailored /personalized medicine format.
Melcap raised in two rounds $3millions from private investors. Recently the company was supported by a $0.6 million investment of Israel Innovation Authority with an option for the same sum in the next year.